DSM promises “business continuity” as it completes €436m omega-3 buy
date:Jul 21, 2012
ring technologies that can be transferred to other parts of its portfolio.

The nutritional lipids category is at an early stage yet well established and is based on strong science, offering significant growth opportunities across a broad range of market segments and applications,DSM said.

DSM can now uniquely offer a full range of products in the rapidly growing nutritional lipids category, offering both fish oil derived omega-3 fatty acids and microbially derived nutritional lipids.

Leendert
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/09 16:22